MoU for promotion of ‘One Herb, One Standard’

September 1, 2022

Recently an MoU has been signed between Pharmacopoeia Commission for Indian Medicine and Homeopathy (Ministry of AYUSH) and Pharmacopoeia Commission of India (Ministry of Health and Family Welfare) to achieve “One Herb, One Standard”.

Key Points

The primary objective of this MoU is to develop collaborative efforts between PCIM&H and IPC to promote public health while facilitating the development of herbal medicine standards.

This MoU will facilitate wider cooperation to promote exchange of information in the field of standardization of traditional medicine. This will be done through sharing of scientific knowledge and information about pharmaceutical raw materials/extracts, seminars, workshops, training and brainstorming programmes.

The MoU will provide an opportunity to all stakeholders such as herbal medicine manufacturers, researchers and regulators to access world-class monographs in their respective fields.

Pharmacopoeia Commission for Indian Medicine

On June 4, 2020, the Union Cabinet chaired by PM Modi approved the Pharmacopoeia commission. The cabinet has approved to re-establish the commission for Indian Medicine and Homeopathy under Ministry of AYUSH.
The commission has been set up by merging Pharmacopoeia Laboratory for Indian Medicine and Homeopathic Pharmacopoeia Laboratory. The two central laboratories were established at Ghaziabad, Uttar Pradesh in 1975.
This commission is an autonomous body that operates under Ministry of AYUSH. It is in operation since 2010.
This merger will also optimize the use of resources and also enhance outcomes of Ayurveda, Unani, Siddha and Homeopathy drugs towards effective quality control.

Significance

Pharmacopoeia means drug making. The Government of India has re-established the Pharmacopoeia Commission of Indian Medicine and Homeopathy. The commission will help to optimize technical manpower, infrastructural facilities, financial resources.

« Previous Post Next Post »